alexa A Challenging Aspect Of AMD: Clinical Features And Treatment Of Pigment Epithelium Detachment
ISSN: 2155-9570

Journal of Clinical & Experimental Ophthalmology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

7th European Ophthalmology Congress
December 05-06, 2016 Madrid, Spain

Ibrahim Kocak
Medipol University, Turkey
ScientificTracks Abstracts: J Clin Exp Ophthalmol
DOI: 10.4172/2155-9570.C1.054
Abstract
Background: Treatment of pigment epithelial (RPE) detachment (PED) is a controversial issue and there are no recommended guidelines for their management. The treatment options have been laser grid or scattered photocoagulation, photodynamic therapy (PDT), anti-vascular endothelial growth factor (VEGF) therapy with ranibizumab or bevacizumab, nevertheless most of them are reported to be ineffective or with high complication rates. Method: Large landmark clinical trials like ANCHOR and MARINA did not report the PED response to ranibizumab treatment. A smaller study, pronto, highlighted the resistance of PEDs to ranibizumab therapy compared to sub-retinal fluid and intra-retinal fluid. Similar results were reported for bevacizumab therapy in terms of sub-RPE fluid resistance. However, some promising reports show efficacy of aflibercept in those resistant cases. In our institution’s experience, we have promising results with aflibercept in PED cases. Results: Aflibercept treatment may have a reasonable rationale by virtue of recalcitrant feature of PED. In previous studies, Major, He, Kanesa, Broadhead all reported reduction in PED dimensions and some of them reported visual acuity improvement. In our institution’s experience, we observed significant decrease in PED dimensions and visual acuity improvement after transitioning aflibercept. Conclusion & Significance: Aflibercept seems to have promising functional and anatomical outcomes in treatment resistant PED cases. Further investigations are needed to provide a recommended treatment guideline and to define more treatment sensitive subtypes of PED.
Biography

Ibrahim Kocak has completed his PhD from Istanbul University and Post-doctoral studies from Istanbul Training Hospital and Medipol University School of Medicine. He is an Assistant Professor in Ophthalmology Department at Medipol University. He has published almost 40 papers in medical journals.

Email: [email protected]

image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords